Tenax Therapeutics
TENX
34 hedge funds and large institutions have $35.9M invested in Tenax Therapeutics in 2025 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 9 increasing their positions, 2 reducing their positions, and 3 closing their positions.
350% more repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 2
267% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 3
178% more capital invested
Capital invested by funds: $12.9M → $35.9M (+$23M)
49.67% more ownership
Funds ownership: 53.8% → 103.47% (+50%)
31% more funds holding
Funds holding: 26 → 34 (+8)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
IC
Ikarian Capital
Dallas,
Texas
|
+$5.91M |
| 2 |
SL
Siren LLC
Greenwich,
Connecticut
|
+$2.15M |
| 3 |
BFM
Boothbay Fund Management
New York
|
+$2.15M |
| 4 |
VA
VR Adviser
New York
|
+$2.07M |
| 5 |
Marshall Wace
London,
United Kingdom
|
+$1.08M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
ADAR1 Capital Management
Austin,
Texas
|
-$624K |
| 2 |
Dimensional Fund Advisors
Austin,
Texas
|
-$93K |
| 3 |
Raymond James Financial
St Petersburg,
Florida
|
-$8.66K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$4.57K |
| 5 |
Barclays
London,
United Kingdom
|
-$63 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Bank of America
Charlotte,
North Carolina
| $1.93K | +$31 | +5 | +2% |
|
27
UBS Group
Zurich,
Switzerland
| $906 | +$641 | +105 | +750% |
|
28
Rockefeller Capital Management
New York
| $15 | +$12 | +2 | New |
|
|
SS
29
SBI Securities
Tokyo,
Japan
| $15 | +$12 | +2 | New |
|
|
AF
30
Allworth Financial
Folsom,
California
| $8 | – | – | – |
|
|
PWA
31
Physician Wealth Advisors
Midvale,
Utah
| $8 | – | – | – |
|
|
WANY
32
Wealthspire Advisors (New York)
New York
| $8 | +$6 | +1 | New |
|
33
Jones Financial Companies
Des Peres,
Missouri
| $7 | – | – | – |
|
|
UBP
34
Union Bancaire Privee
Geneva 1,
Switzerland
| $6 | – | – | – |
|
|
35
Dimensional Fund Advisors
Austin,
Texas
| – | -$93K | -15,930 | Closed |
|
|
36
Raymond James Financial
St Petersburg,
Florida
| – | -$8.66K | -1,503 | Closed |
|
|
37
Barclays
London,
United Kingdom
| – | -$63 | -11 | Closed |
|
TENX Hedge Fund Activity: Q3 2025 in Review
34 of the 7,626 institutional investors tracked by Wall St. Rank reported a position in Tenax Therapeutics (TENX) for Q3 2025, worth a combined $35.9M — up 178% from $12.9M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new TENX positions and 3 closed out — a net gain of 8 holders — while 9 added to existing stakes and 2 trimmed.
The largest buyer was Ikarian Capital, opening a new position worth an estimated $5.91M. The largest seller was ADAR1 Capital Management, cutting an estimated $624K.
- 34 institutional investors held Tenax Therapeutics (TENX) as of Q3 2025, up from 26 in Q2 2025.
- Funds reported $35.9M of Tenax Therapeutics stock for Q3 2025, up 178% quarter-over-quarter.
- 11 funds opened new Tenax Therapeutics positions in Q3 2025 and 3 closed out, a net change of +8 holders.
- The largest Tenax Therapeutics buyer in Q3 2025 was Ikarian Capital, an estimated $5.91M added.
- The largest Tenax Therapeutics seller in Q3 2025 was ADAR1 Capital Management, an estimated $624K sold.
Based on aggregated 13F filings for Q3 2025.